Abstract: The invention relates to an in vitro method for prognosis, diagnosis or determination of the evolution of a condition involving an altered production of Basic Proline-rich Lacrimal Protein (BPLP) or of any of its maturation products, by detecting, or quantifying in a biological sample of a test subject, a BPLP protein or a maturation product thereof, and comparing the production of BPLP protein or maturation product with the production of the same in a biological sample of a control subject.

Abstract: The invention relates to an in vitro method for prognosis, diagnosis or determination of the evolution of a condition involving an altered production of Basic Proline-rich Lacrimal Protein (BPLP) or of any of its maturation products, by detecting, or quantifying in a biological sample of a test subject, a BPLP protein or a maturation product thereof, and comparing the production of BPLP protein or maturation product with the production of the same in a biological sample of a control subject

Abstract: The invention relates to an in vitro method for prognosis, diagnosis or determination of the evolution of a condition involving an altered production of Basic Proline-rich Lacrimal Protein (BPLP) or of any of its maturation products, by detecting, or quantifying in a biological sample of a test subject, a BPLP protein or a maturation product thereof, and comparing the production of BPLP protein or maturation product with the production of the same in a biological sample of a control subject.

Abstract: The invention relates to an in vitro method for prognosis, diagnosis or determination of the evolution of a condition involving an altered production of Basic Proline-rich Lacrimal Protein (BPLP) or of any of its maturation products, by detecting, or quantifying in a biological sample of a test subject, a BPLP protein or a maturation product thereof, and comparing the production of BPLP protein or maturation product with the production of the same in a biological sample of a control subject

Abstract: The invention relates to an in vitro method for prognosis, diagnosis or determination of the evolution of a condition involving an altered production of Basic Proline-rich Lacrimal Protein (BPLP) or of any of its maturation products, by detecting, or quantifying in a biological sample of a test subject, a BPLP protein or a maturation product thereof, and comparing the production of BPLP protein or maturation product with the production of the same in a biological sample of a control subject.

Abstract: Exemplary embodiments of the present invention relate to a method for advertising a business enterprise via an instant messaging (IM) environment comprising registering at least one business enterprise computing system application with an IM server and registering at least one subscriber with the IM server, wherein a subscriber logs on to the IM server via an IM client application that resides at a computing device.

Abstract: The invention relates to an in vitro method for prognosis, diagnosis or determination of the evolution of a condition involving an altered production of Basic Proline-rich Lacrimal Protein (BPLP) or of any of its maturation products, by detecting, or quantifying in a biological sample of a test subject, a BPLP protein or a maturation product thereof, and comparing the production of BPLP protein or maturation product with the production of the same in a biological sample of a control subject.

Abstract: The invention relates to a peptide that is a maturation product of the Basic Prolin-rich Lacrinal Protein (BPLP) or a peptide derivative of said maturation product, wherein the peptide or peptide derivative exhibits an inhibitory property against a metallo-ectopeptidase, especially NEP and/or APN. The present invention also relates to polynucleotides coding for said peptides and to antibodies directed against said peptides. Furthermore, the present invention relates to diagnostic and therapeutic uses of human BPLP protein and inhibitory peptides derived therefrom, polypeptides coding for human BPLP protein or peptides derived therefrom as well as antibodies directed against BPLP protein or peptides derived therefrom.

Abstract: A computer-implemented method for specifying the characteristics of a desired item includes specifying a plurality of items, each of which possess at least one but not all characteristics of the desired item, selecting a subset of characteristics from each of said plurality of items, combining selected subsets of characteristics into a characterization of the desired item, and validating an availability of the desired item.

Abstract: Exemplary embodiments of the present invention relate to a method for interacting with and controlling infrastructure devices within an IM environment. The method comprises registering at least one infrastructure device at an IM server, registering at least one computing device at the IM server, and delivering one or more of infrastructure device characteristics, status information, and service information from a registered infrastructure device to the IM server, wherein the IM server is configured to publish and update the infrastructure device characteristics, status information, and service information from the at least one registered infrastructure device to registered computing devices.

Abstract: Exemplary embodiments of the present invention relate to a method for interacting with and controlling infrastructure devices within an IM environment. The method comprises registering at least one infrastructure device at an IM server, registering at least one computing device at the IM server, and delivering one or more of infrastructure device characteristics, status information, and service information from a registered infrastructure device to the IM server, wherein the IM server is configured to publish and update the infrastructure device characteristics, status information, and service information from the at least one registered infrastructure device to registered computing devices.

Abstract: Exemplary embodiments of the present invention relate to a method for advertising a business enterprise via an instant messaging (IM) environment comprising registering at least one business enterprise computing system application with an IM server and registering at least one subscriber with the IM server, wherein a subscriber logs on to the IM server via an IM client application that resides at a computing device.

Abstract: A system and method for enabling user preferences and device characteristics to be used to generate a customized interface for services and particularly, for enabling interaction between heterogeneous mobile devices and services in a local environment through one's device. The system automates the creation of custom mobile interfaces for service interaction, since the author of a service is typically unaware of the different types of devices that will utilize the service. The method includes communicating, when a service is invoked, the input capabilities of the device to a service broker along with preferences of the user. The characteristics and functionality of the service is included in the specification of the service. A mapping function maps the triad of user preferences, device description, and service functions to optimize the placement of the services' functions (interfaces) on to the device's input controls while taking the user preferences and device output controls into account.

Abstract: The invention relates to a peptide that is a maturation product of the Basic Prolin-rich Lacrinal Protein (BPLP) or a peptide derivative of said maturation product, wherein the peptide or peptide derivative exhibits an inhibitory property against a metallo-ectopeptidase, especially NEP and/or APN. The present invention also relates to polynucleotides coding for said peptides and to antibodies directed against said peptides. Furthermore, the present invention relates to diagnostic and therapeutic uses of human BPLP protein and inhibitory peptides derived therefrom, polypeptides coding for human BPLP protein or peptides derived therefrom as well as antibodies directed against BPLP protein or peptides derived therefrom.

Abstract: A system and method for constructing a high-quality interface for interacting with a Web service are provided. The method in one aspect includes specifying a service description to associate with an interface of a Web service in a service description language, specifying expected usage information of the Web service, the expected use information including at least grouping of service operations, probability and relative importance of service operations, and constructing the interface for a client interacting with the Web service based on the service description and the expected usage information. The system in one aspect includes means for performing the method steps.

Abstract: A computer-implemented method for specifying the characteristics of a desired item includes specifying a plurality of items, each of which possess at least one but not all characteristics of the desired item, selecting a subset of characteristics from each of said plurality of items, combining selected subsets of characteristics into a characterization of the desired item, and validating an availability of the desired item.